NLS

Victor Ambros, Professor of Molecular Medicine and the Silverman Chair in Natural Sciences at the University of Massachusetts Chan Medical School, is one of this year’s winners of the Nobel Prize in Physiology or Medicine.

Four months after XNK Therapeutics, located in Huddinge, Sweden, declared bankruptcy, the clinical-stage biotechnology company’s building and physical assets were sold and the lease agreement transferred to BioLamina. 

Downsizing a company is one of the most difficult decisions a chief executive can make, after which comes the equally painful decision of when to do it.

His is not a household name, but the drugs developed thanks to Danish scientist Jens Juul Holst’s research certainly are.

Despite being the co-founder of Ilya Pharma and co-director at the Science for Life Laboratory (SciLifeLab), Dr. Mia Phillipson, considers herself a scientist foremost, not an entrepreneur. “Most of all, I am a scientist. Yes, absolutely. This is my main occupation and the one in which I have the most expertise,” says Mia Phillipson, who […]

Personalized medicine, weight loss remedies and new treatments for widespread ailments are among the rising areas of high interest in the biotechnology and therapeutic arenas, according to executive chairman of Flerie Invest, Thomas Eldered. Thomas Eldered talked with Nordic Life Science about the Nordic and global life science financial landscapes and Flerie’s role in funding […]